Skip to main content

Congress reviews Wyeth’s conduct in media claims regarding its products


NEW YORK Wyeth has come under scrutiny in Congress amid allegations that its marketing department helped influence articles about its products published in medical journals.

Sen. Charles Grassley, R-Iowa, has asked Wyeth and DesignWrite, a company that Wyeth hired, to disclose payments allegedly made to influence the content of articles about Wyeth products such as the menopause drug Prempro (conjugated estrogens/medroxy-progesterone acetate), as well as information about doctors whose names appeared in the articles.

The Senate Finance Committee has sought to investigate the practice of medical ghostwriting and drug makers’ influence over health care.

“Shedding light on the relationships between drug companies and authors helps establish accountability and safeguard the credibility of influential medical journals,” Grassley said. 

This ad will auto-close in 10 seconds